Europe Intradermal Injections Market Forecast to 2028 – COVID

Europe Intradermal Injections Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Method (Normal Sized Needle, Short Needle, and Without Needle), Application (Tuberculin Skin Test, Allergy Test, Local Aesthetics, and Others), and End User (Hospitals, Diagnostic Laboratories, Academics and Research Institutes, and Others)

Report Code : TIPRE00027988 | Region : Europe | Industry : Pharmaceuticals | Published Date : 23/Nov/2022

The intradermal injections market in Europe is expected to grow from US$ 1,029.42 million in 2021 to US$ 2,131.06 million by 2028. It is estimated to grow at a CAGR of 11.0% from 2021 to 2028.

Increasing Incidence of Communicable and Noncommunicable Diseases Boost Market Growth

The incidence of several communicable and noncommunicable diseases has increased exponentially in the last few years, mainly due to the unhealthy lifestyle of the modern world. Smoking, infections, and genetic factors can cause serious respiratory complications, cardiovascular disorders, and bacterial and viral infections, etc. These diseases are among the medical conditions exerting a huge burden on the public healthcare system in various countries. Per the data by the WHO, ~10 million cases of tuberculosis are observed every year and all of them are diagnosed using a tuberculin skin test, which involves the use of intradermal injections. Several studies suggest that intradermal injections could improve the absorption of various anticancer and immunological drugs, and they can also be used to deliver gene therapies. Tropis ID of Pharmajet, one of the Novel intradermal injection devices, offers prominent results in delivering various drugs targeting a wide range of diseases.

Market Overview

The UK, Germany, France, Italy, Spain, and the Rest of Europe are the key contributors to the intradermal injections market in Europe. Germany dominates the market in this region. Various medical players in Germany manufacture cost-effective products with superior quality. Germany is the second largest market for medical devices after the US. According to AIM, an IGES Group company, the medical device market in Germany is valued at US$ 28.25 billion (25 billion euros). Additionally, the government in the country has made health insurance mandatory for citizens. ~71.4 million people in Germany are covered by Gesetzliche Krankenversicherung (GKV), which is a public health insurance, and ~8.8 million people are covered by the Private Krankenversicherung (PKV) through state aid, which is a private health insurance. According to the WHO data, the detection rate of tuberculosis cases was ~87% in 2020. Further, the incidence rate of tuberculosis in Germany is ~5.5 per 100,000 population, which indicates the elevating need for intradermal injections. The expanding elderly population and the rising prevalence of allergic reactions are also propelling the German market for intradermal injections. The country has more than 400 hospitals dedicated to the geriatric population. Therefore, the demand for advanced medical equipment, such as needle-free injections, is high in this country. With the high acceptance of cosmetic procedures, the use of intradermal injections in aesthetic procedures is also on rise in the country. Grabbing these opportunities, Germany invests significantly in healthcare research and infrastructure. According to Eurostat, the healthcare expenditure in Germany accounted for US$ 394.9 million in 2015. Along with this, various leading companies are investing in medical device manufacturing in Germany.

Europe Intradermal Injections Market Segmentation

The Europe intradermal injections market is segmented on the basis of method, application, end user, and country.

Based on method, the market is segmented into normal sized needle, short needle, and without needle. The normal sized needles segment registered the largest market share in 2021. The normal sized needles segment is further sub segmented into intradermal microinjections, microneedle arrays, and tattoo devices. The short needle segment is bifurcated into intradermal liquid jet injectors and ballistic intradermal injectors.

In terms of application, the Europe intradermal injections market is segmented into tuberculin skin test, allergy test, local aesthetics, and others. The tuberculin skin test segment held the largest market share in 2021.

The Europe intradermal injections market, by end user, is segmented into hospitals, diagnostic laboratories, academics and research institutes, and others. The hospitals segment held the largest market share in 2021.

Based on country, the market is segmented into the UK, Germany, France, Italy, Spain, and rest of Europe. Germany dominated the market in 2021.

BD; West Pharmaceutical Services, Inc; Terumo Corporation; Nanopass; PharmaJet; Idevax; EUNSUNG GLOBAL; Crossject; Cardinal Health Inc; and Hindustan Syringes and Medical Devices Ltd are the leading companies operating in intradermal injections market in the Europe region.

At 11.0% CAGR, the Europe Intradermal injection Market is speculated to be worth US$ 2,131.06 million by 2028, says The Insight Partners

According to the Insight Partners’ research, the Europe intradermal injection market was valued at US$ 1,029.42 million in 2021 and is expected to reach US$ 2,131.06 million by 2028, registering an annual growth rate of 11.0% from 2021 to 2028. Increasing intradermal vaccination and increasing incidences of diseases are the critical factors attributed to the market expansion.

Rising acceptance of intradermal vaccination is believed to act as major driver for the Europe intradermal injection market as it has several advantages over the conventional method of vaccination. Intradermal vaccination helps in reducing the potential dose of antigens, improves the immune response generated by the vaccine and decrease the anxiety associated with the vaccination. By developing intradermal injection, a large population can be vaccinated with comparatively lesser production of the vaccine while this method is also able to vaccinate the difficult group of population with comorbidities as chances of adverse events is low as compared to conventional vaccination. Recently, several intradermal COVID19 vaccines, hepatitis A vaccine, hepatitis B vaccine, Influenza vaccines, polio vaccine measles vaccine, Rabies vaccine, tetanus vaccine, yellow fever vaccine, diphtheria-tetanus-pertussis vaccine etc. shows improvement in the overall response rate and hence several leading pharmaceutical and biotechnological companies are currently working on the development of intradermal injections of the new as well as commercially available vaccines. Therefore, the efforts made by the leading manufactures is believed to drive the growth rate of this market segment.

On the contrary, risks, complications, and dosing limitations associated with intradermal injections hurdles the growth of Europe intradermal injection market.

Based on method, the Europe intradermal injection market is segmented into normal sized needles, short needle, and without needle. The normal sized needles segment held 38.9% market share in 2021, amassing US$ 400.12 million. It is projected to garner US$ 798.76 million by 2028 to expand at 10.4% CAGR during 2021–2028. The normal sized needles segment is further sub segmented into intradermal microinjection, microneedle arrays, and tattoo devices. The short needle segment is further sub segmented intradermal liquid jet injectors and ballistic intradermal injectors.

Based on application, the Europe intradermal injection market is segmented into tuberculin skin test, allergy test, local aesthetics, and others. The tuberculin skin test segment held 29.0% market share in 2021, amassing US$ 298.12 million. It is projected to garner US$ 607.33 million by 2028 to expand at 10.7% CAGR during 2021–2028.

Based on end user, the Europe intradermal injection market is segmented into hospitals, diagnostic laboratories, academics and research institutes, and others. The hospitals segment held 39.8% market share in 2021, amassing US$ 409.52 million. It is projected to garner US$ 855.35 million by 2028 to expand at 11.1% CAGR during 2021–2028.

Based on country, the Europe intradermal injection market has been categorized into UK, Germany, France, Italy, Spain, and rest of Europe. Our regional analysis states that Germany captured 25.5% market share in 2021. It was assessed at US$ 262.48 million in 2021 and is likely to hit US$ 549.98 million by 2028, exhibiting a CAGR of 11.1% during the forecast period.

Key players profiles in the Europe intradermal injection market report are BD; West Pharmaceutical Services, Inc; Terumo Corporation; Nanopass; PharmaJet; Idevax; EUNSUNG GLOBAL; Crossject; Cardinal Health Inc; and Hindustan Syringes and Medical Devices Ltd, among others.

TABLE OF CONTENTS

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 Europe Intradermal Injections Market – By Method

1.3.2 Europe Intradermal Injections Market – By Application

1.3.3 Europe Intradermal Injections Market – By End User

1.3.4 Europe Intradermal Injections Market – By Country

2. Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Europe Intradermal Injections Market Landscape

4.1 Overview

4.2 EUROPE PEST ANALYSIS

4.2.1 Europe PEST Analysis

4.3 EXPERT OPINIONS

5. Europe Intradermal Injections Market - Key Market Dynamics

5.1 Key Market Drivers

5.1.1 Increasing Intradermal Vaccination

5.1.2 Increasing Incidences of diseases

5.1.3 Rising Acceptance of Aesthetic Procedures

5.2 Key Market Restraints

5.2.1 Risks, Complications, and Dosing Limitations Associated with Intradermal Injections

5.3 Key Market Opportunities

5.3.1 Significant Growth Opportunities in Developed as Well As Developing Countries

5.4 Future Trends

5.4.1 Strategic Developments by Manufacturers

5.5 Impact Analysis of Drivers and Restraints

6. Intradermal Injections Market– Europe Analysis

6.1 Europe Intradermal Injections Market, By Country - Forecast and Analysis

7. Europe Intradermal Injections Market Revenue and Forecasts To 2028– By Method

7.1 Overview

7.2 Europe Intradermal Injections Market, By Method, 2021 & 2028 (%)

7.3 Normal-Sized Needles (MANTOUX)

7.3.1 Overview

7.3.2 Normal-Sized Needles (Mantoux): Intradermal Injection Market Revenue and Forecasts To 2028 (US$ MN)

7.4 Short Needles

7.4.1 Overview

7.4.2 Short Needles: Intradermal Injection Market Revenue and Forecast to 2028 (US$ Million)

7.4.3 Intradermal Microinjection

7.4.3.1 Overview

7.4.3.2 Intradermal Microinjection: Intradermal Injection Market Revenue and Forecast to 2028 (US$ Million)

7.4.4 Microneedle Arrays

7.4.4.1 Overview

7.4.4.2 Microneedle Arrays: Intradermal Injection Market Revenue and Forecast to 2028 (US$ Million)

7.4.5 Tattoo Devices

7.4.5.1 Overview

7.4.5.2 Tattoo Devices: Intradermal Injection Market Revenue and Forecast to 2028 (US$ Million)

7.5 Without Needles

7.5.1 Overview

7.5.2 Without Needles: Intradermal Injection Market Revenue and Forecast to 2028 (US$ Million)

7.5.3 Intradermal Liquid Jet Injectors

7.5.3.1 Overview

7.5.3.2 Intradermal Liquid Jet Injectors: Intradermal Injection Market Revenue and Forecast to 2028 (US$ Million)

7.5.4 Ballistic Intradermal Injectors

7.5.4.1 Overview

7.5.4.2 Ballistic Intradermal Injectors: Intradermal Injection Market Revenue and Forecast to 2028 (US$ Million)

8. Europe Intradermal Injections Market Revenue and Forecasts To 2028 – Application

8.1 Overview

8.2 Europe Intradermal Injections Market Share by Application - 2021 & 2028 (%)

8.3 Tuberculin Skin Testing

8.3.1 Overview

8.3.2 Tuberculin Skin Testing Market Revenue and Forecast to 2028 (US$ Million)

8.4 Allergy Testing

8.4.1 Overview

8.4.2 Allergy Testing Market Revenue and Forecast to 2028 (US$ Million)

8.5 Local Aesthetics

8.5.1 Overview

8.5.2 Local Aesthetics Market Revenue and Forecast to 2028 (US$ Million)

8.6 OTHERS

8.6.1 Overview

8.6.2 Others Market Forecast and Analysis

9. Europe Intradermal Injections Market Analysis - End User

9.1 Overview

9.2 Europe Intradermal Injections Market, By End User, 2021 & 2028 (%)

9.3 Hospitals

9.3.1 Overview

9.3.2 Hospitals: Intradermal Injections Market Revenue and Forecast to 2028 (US$ Million)

9.4 Diagnostic Laboratories

9.4.1 Overview

9.4.2 Diagnostic Laboratories: Intradermal Injections Market Revenue and Forecast to 2028 (US$ Million)

9.5 Academic and Research Institutes

9.5.1 Overview

9.5.2 Academic and Research Institutes: Intradermal Injections Market Revenue and Forecast to 2028 (US$ Million)

9.6 OTHERS

9.6.1 Overview

9.6.2 Others: Intradermal Injections Market Revenue and Forecast to 2028 (US$ Million)

10. Europe Intradermal Injections Market Revenue and Forecasts To 2028 – Country Analysis

10.1 Europe: Intradermal Injections Market

10.1.1 Overview

10.1.2 Europe: Intradermal Injections Market, by Country, 2021 & 2028 (%)

10.1.2.1 Germany: Intradermal Injections Market – Revenue and Forecast to 2028 (US$ Million)

10.1.2.1.1 Overview

10.1.2.1.2 Germany: Intradermal Injections Market – Revenue and Forecast to 2028 (US$ Million)

10.1.2.1.3 Germany: Intradermal Injections Market, by Method – Revenue and Forecast to 2028 (US$ Million)

10.1.2.1.3.1 Germany: Intradermal Injections Market, by Short Needles, 2019–2028 (US$ Million)

10.1.2.1.3.2 Germany: Intradermal Injections Market, by Without Needles, 2019–2028 (US$ Million)

10.1.2.1.4 Germany: Intradermal Injections Market, by Application– Revenue and Forecast to 2028 (US$ Million)

10.1.2.1.5 Germany: Intradermal Injections Market, by End User – Revenue and Forecast to 2028 (US$ Million)

10.1.2.2 France: Intradermal Injections Market – Revenue and Forecast to 2028 (US$ Million)

10.1.2.2.1 Overview

10.1.2.2.2 France: Intradermal Injections Market – Revenue and Forecast to 2028 (US$ Million)

10.1.2.2.3 France: Intradermal Injections Market, by Method – Revenue and Forecast to 2028 (US$ Million)

10.1.2.2.3.1 France: Intradermal Injections Market, by Short Needles, 2019–2028 (US$ Million)

10.1.2.2.3.2 France: Intradermal Injections Market, by Without Needles, 2019–2028 (US$ Million)

10.1.2.2.4 France: Intradermal Injections Market, by Application– Revenue and Forecast to 2028 (US$ Million)

10.1.2.2.5 France: Intradermal Injections Market, by End User – Revenue and Forecast to 2028 (US$ Million)

10.1.2.3 UK: Intradermal Injections Market – Revenue and Forecast to 2028 (US$ Million)

10.1.2.3.1 Overview

10.1.2.3.2 UK: Intradermal Injections Market – Revenue and Forecast to 2028 (US$ Million)

10.1.2.3.3 UK: Intradermal Injections Market, by Method – Revenue and Forecast to 2028 (US$ Million)

10.1.2.3.3.1 UK: Intradermal Injections Market, by Short Needles, 2019–2028 (US$ Million)

10.1.2.3.3.2 UK: Intradermal Injections Market, by Without Needles, 2019–2028 (US$ Million)

10.1.2.3.4 UK: Intradermal Injections Market, by Application– Revenue and Forecast to 2028 (US$ Million)

10.1.2.3.5 UK: Intradermal Injections Market, by End User – Revenue and Forecast to 2028 (US$ Million)

10.1.2.4 Italy: Intradermal Injections Market – Revenue and Forecast to 2028 (US$ Million)

10.1.2.4.1 Overview

10.1.2.4.2 Italy: Intradermal Injections Market – Revenue and Forecast to 2028 (US$ Million)

10.1.2.4.3 Italy: Intradermal Injections Market, by Method – Revenue and Forecast to 2028 (US$ Million)

10.1.2.4.3.1 Italy: Intradermal Injections Market, by Short Needles, 2019–2028 (US$ Million)

10.1.2.4.3.2 Italy: Intradermal Injections Market, by Without Needles, 2019–2028 (US$ Million)

10.1.2.4.4 Italy: Intradermal Injections Market, by Application– Revenue and Forecast to 2028 (US$ Million)

10.1.2.4.5 Italy: Intradermal Injections Market, by End User – Revenue and Forecast to 2028 (US$ Million)

10.1.2.5 Spain: Intradermal Injections Market – Revenue and Forecast to 2028 (US$ Million)

10.1.2.5.1 Overview

10.1.2.5.2 Spain: Intradermal Injections Market – Revenue and Forecast to 2028 (US$ Million)

10.1.2.5.3 Spain: Intradermal Injections Market, by Method – Revenue and Forecast to 2028 (US$ Million)

10.1.2.5.3.1 Spain: Intradermal Injections Market, by Short Needles, 2019–2028 (US$ Million)

10.1.2.5.3.2 Spain: Intradermal Injections Market, by Without Needles, 2019–2028 (US$ Million)

10.1.2.5.4 Spain: Intradermal Injections Market, by Application– Revenue and Forecast to 2028 (US$ Million)

10.1.2.5.5 Spain: Intradermal Injections Market, by End User – Revenue and Forecast to 2028 (US$ Million)

10.1.2.6 Rest of Europe: Intradermal Injections Market – Revenue and Forecast to 2028 (US$ Million)

10.1.2.6.1 Overview

10.1.2.6.2 Rest of Europe: Intradermal Injections Market – Revenue and Forecast to 2028 (US$ Million)

10.1.2.6.3 Rest of Europe: Intradermal Injections Market, by Method – Revenue and Forecast to 2028 (US$ Million)

10.1.2.6.3.1 Rest of Europe: Intradermal Injections Market, by Short Needles, 2019–2028 (US$ Million)

10.1.2.6.3.2 Rest of Europe: Intradermal Injections Market, by Without Needles, 2019–2028 (US$ Million)

10.1.2.6.4 Rest of Europe: Intradermal Injections Market, by Application– Revenue and Forecast to 2028 (US$ Million)

10.1.2.6.5 Rest of Europe: Intradermal Injections Market, by End User – Revenue and Forecast to 2028 (US$ Million)

11. Industry Landscape

11.1 Overview

11.2 Developments

11.2.1 Overview

12. Company Profiles

12.1 BD

12.1.1 Key Facts

12.1.2 Business Description

12.1.3 Products and Services

12.1.4 Financial Overview

12.1.5 SWOT Analysis

12.1.6 Key Developments

12.2 West Pharmaceutical Services, Inc.

12.2.1 Key Facts

12.2.2 Business Description

12.2.3 Products and Services

12.2.4 Financial Overview

12.2.5 SWOT Analysis

12.2.6 Key Developments

12.3 Terumo Corporation

12.3.1 Key Facts

12.3.2 Business Description

12.3.3 Products and Services

12.3.4 Financial Overview

12.3.5 SWOT Analysis

12.3.6 Key Developments

12.4 NanoPass

12.4.1 Key Facts

12.4.2 Business Description

12.4.3 Products and Services

12.4.4 Financial Overview

12.4.5 SWOT Analysis

12.4.6 Key Developments

12.5 Pharmajet

12.5.1 Key Facts

12.5.2 Business Description

12.5.3 Products and Services

12.5.4 Financial Overview

12.5.5 SWOT Analysis

12.5.6 Key Developments

12.6 Idevax

12.6.1 Key Facts

12.6.2 Business Description

12.6.3 Products and Services

12.6.4 Financial Overview

12.6.5 SWOT Analysis

12.6.6 Key Developments

12.7 EUNSUNG GLOBAL

12.7.1 Key Facts

12.7.2 Business Description

12.7.3 Products and Services

12.7.4 Financial Overview

12.7.5 SWOT Analysis

12.7.6 Key Developments

12.8 Crossject

12.8.1 Key Facts

12.8.2 Business Description

12.8.3 Products and Services

12.8.4 Financial Overview

12.8.5 SWOT Analysis

12.8.6 Key Developments

12.9 Cardinal Health Inc.

12.9.1 Key Facts

12.9.2 Business Description

12.9.3 Products and Services

12.9.4 Financial Overview

12.9.5 SWOT Analysis

12.9.6 Key Developments

12.10 Hindustan Syringes and Medical Devices Ltd

12.10.1 Key Facts

12.10.2 Business Description

12.10.3 Products and Services

12.10.4 Financial Overview

12.10.5 SWOT Analysis

12.10.6 Key Developments

13. Appendix

13.1 About The Insight Partners

13.2 Glossary of Terms

LIST OF TABLES.

Table 1. Germany: Intradermal Injections Market, by Method – Revenue and Forecast to 2028 (US$ Million)

Table 2. Germany: Intradermal Injections Market, by Short Needles – Revenue and Forecast to 2028 (US$ Million)

Table 3. Germany: Intradermal Injections Market, by Without Needles – Revenue and Forecast to 2028 (US$ Million)

Table 4. Germany: Intradermal Injections Market, by Application– Revenue and Forecast to 2028 (US$ Million)

Table 5. Germany: Intradermal Injections Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 6. France: Intradermal Injections Market, by Method – Revenue and Forecast to 2028 (US$ Million)

Table 7. France: Intradermal Injections Market, by Short Needles – Revenue and Forecast to 2028 (US$ Million)

Table 8. France: Intradermal Injections Market, by Without Needles – Revenue and Forecast to 2028 (US$ Million)

Table 9. France: Intradermal Injections Market, by Application– Revenue and Forecast to 2028 (US$ Million)

Table 10. France: Intradermal Injections Market

Table 11. France: Intradermal Injections Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 12. UK: Intradermal Injections Market, by Method – Revenue and Forecast to 2028 (US$ Million)

Table 13. UK: Intradermal Injections Market, by Short Needles – Revenue and Forecast to 2028 (US$ Million)

Table 14. UK: Intradermal Injections Market, by Without Needles – Revenue and Forecast to 2028 (US$ Million)

Table 15. UK: Intradermal Injections Market, by Application– Revenue and Forecast to 2028 (US$ Million)

Table 16. UK: Intradermal Injections Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 17. Italy: Intradermal Injections Market, by Method – Revenue and Forecast to 2028 (US$ Million)

Table 18. Italy: Intradermal Injections Market, by Short Needles – Revenue and Forecast to 2028 (US$ Million)

Table 19. Italy: Intradermal Injections Market, by Without Needles – Revenue and Forecast to 2028 US$ Million)

Table 20. Italy: Intradermal Injections Market, by Application– Revenue and Forecast to 2028 (US$ Million)

Table 21. Italy: Intradermal Injections Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 22. Spain: Intradermal Injections Market, by Method – Revenue and Forecast to 2028 (US$ Million)

Table 23. Spain: Intradermal Injections Market, by Short Needles – Revenue and Forecast to 2028 (US$ Million)

Table 24. Spain: Intradermal Injections Market, by Without Needles – Revenue and Forecast to 2028 (US$ Million)

Table 25. Spain: Intradermal Injections Market, by Application– Revenue and Forecast to 2028 (US$ Million)

Table 26. Spain: Intradermal Injections Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 27. Rest of Europe: Intradermal Injections Market, by Method – Revenue and Forecast to 2028 (US$ Million)

Table 28. Rest of Europe: Intradermal Injections Market, by Short Needles – Revenue and Forecast to 2028 (US$ Million)

Table 29. Rest of Europe: Intradermal Injections Market, by Without Needles – Revenue and Forecast to 2028 (US$ Million)

Table 30. Rest of Europe: Intradermal Injections Market, by Application– Revenue and Forecast to 2028 (US$ Million)

Table 31. Rest of Europe: Intradermal Injections Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 32. Developments Done by Companies

Table 33. Glossary of Terms

LIST OF FIGURES.

Figure 1. Europe Intradermal Injections Market Segmentation

Figure 2. Europe Intradermal Injections Market, By Country

Figure 3. Europe Intradermal Injections Market Overview

Figure 4. Europe Intradermal Injection Market, By Method

Figure 5. Europe Intradermal Injection Market, By Country

Figure 7. EXPERT OPINIONS

Figure 8. Europe Intradermal Injection Market Impact Analysis of Drivers and Restraints

Figure 9. Europe Intradermal Injections Market – Revenue Forecast and Analysis – 2019- 2028

Figure 10. Europe Intradermal Injections Market, by Method, 2021 & 2028 (%)

Figure 11. Europe Normal-Sized Needles (Mantoux): Intradermal Injection Market Revenue and Forecasts to 2028 (US$ Million)

Figure 12. Europe Short Needles: Intradermal Injection Market Revenue and Forecasts to 2028 (US$ Million)

Figure 13. Europe Intradermal Microinjection: Intradermal Injection Market Revenue and Forecasts to 2028 (US$ Million)

Figure 14. Europe Microneedle Arrays: Intradermal Injection Market Revenue and Forecasts to 2028 (US$ Million)

Figure 15. Europe Tattoo Devices: Intradermal Injection Market Revenue and Forecasts to 2028 (US$ Million)

Figure 16. Europe Without Needle: Intradermal Injection Market Revenue and Forecasts to 2028 (US$ Million)

Figure 17. Europe Intradermal Liquid Jet Injectors: Intradermal Injection Market Revenue and Forecasts to 2028 (US$ Million)

Figure 18. Europe Ballistic Intradermal Injectors: Intradermal Injection Market Revenue and Forecasts to 2028 (US$ Million)

Figure 19. Europe Intradermal Injections Market Share by Application - 2021 & 2028 (%)

Figure 20. Europe Tuberculin Skin Test Market Revenue and Forecasts to 2028 (US$ Million)

Figure 21. Europe Allergy Testing Market Revenue and Forecasts to 2028 (US$ Million)

Figure 22. Europe Local Aesthetic Market Revenue and Forecasts to 2028 (US$ Million)

Figure 23. Europe Others Intradermal Market Revenue and Forecasts to 2028 (US$ Million)

Figure 24. Europe Intradermal Injections Market, by End User, 2021 & 2028 (%)

Figure 25. Europe Hospital: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)

Figure 26. Europe Diagnostic Laboratories: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)

Figure 27. Europe Academic & Research Institutes: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)

Figure 28. Europe Others: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)

Figure 29. Europe: Intradermal Injections Market, by Key Country – Revenue (2021) (US$ Million)

Figure 30. Europe: Intradermal Injections Market, by Country, 2021 & 2028 (%)

Figure 31. Germany: Intradermal Injections Market – Revenue and Forecast to 2028 (US$ Million)

Figure 32. France: Intradermal Injections Market – Revenue and Forecast to 2028 (US$ Million)

Figure 33. UK: Intradermal Injections Market – Revenue and Forecast to 2028 (US$ Million)

Figure 34. Italy: Intradermal Injections Market – Revenue and Forecast to 2028 (US$ Million)

Figure 35. Spain: Intradermal Injections Market – Revenue and Forecast to 2028 (US$ Million)

Figure 36. Rest of Europe: Intradermal Injections Market – Revenue and Forecast to 2028 (US$ Million)

The List of Companies - Europe Intradermal Injections Market

● BD

● West Pharmaceutical Services, Inc.

● Terumo Corporation

● Nanopass

● PharmaJet

● Idevax

● EUNSUNG GLOBAL

● Crossject

● Cardinal Health Inc.

● Hindustan Syringes and Medical Devices Ltd.

● Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe intradermal injections market.

● Highlights key business priorities in order to assist companies to realign their business strategies

● The key findings and recommendations highlight crucial progressive industry trends in the Europe intradermal injections market, thereby allowing players across the value chain to develop effective long-term strategies

● Develop/modify business expansion plans by using substantial growth offering developed and emerging markets

● Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the intradermal injections market, as well as those hindering it

● Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

TOP